One important metric to look for in a stock is an 80 or higher Relative Strength Rating. Calumet just hit that mark, with a jump from 78 to 82 Monday.
IBD's unique rating measures share price action with a 1 (worst) to 99 (best) score. The grade shows how a stock's price behavior over the last 52 weeks compares to all the other stocks in our database.
History reveals that the stocks that go on to make the biggest gains typically have an RS Rating north of 80 as they launch their biggest price moves.
Hone Your Stock-Picking Skills By Focusing On These Factors
Calumet is building a consolidation with a 25.29 buy point. See if the stock can clear the breakout price in heavy trading.
Calumet posted 0% earnings growth last quarter. Sales rose -4%.
The company holds the No. 9 rank among its peers in the Oil & Gas-Refining/Marketing industry group. Global Partners, Targa Resources and UGI are among the top 5 highly rated stocks within the group.
RELATED:
Which Stocks Are Showing Rising Relative Strength?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
